NCT05000294 2026-06-05Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesUniversity of FloridaPhase 1/2 Recruiting29 enrolled
NCT01782313 2019-09-09A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue SarcomasNorthwestern UniversityPhase 2 Completed58 enrolled 13 charts